KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Raw Materials (2016 - 2025)

Historic Raw Materials for Pacific Biosciences Of California (PACB) over the last 16 years, with Q3 2025 value amounting to $41.8 million.

  • Pacific Biosciences Of California's Raw Materials rose 3613.06% to $41.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.8 million, marking a year-over-year increase of 3613.06%. This contributed to the annual value of $45.3 million for FY2024, which is 3957.58% up from last year.
  • Latest data reveals that Pacific Biosciences Of California reported Raw Materials of $41.8 million as of Q3 2025, which was up 3613.06% from $46.0 million recorded in Q2 2025.
  • Over the past 5 years, Pacific Biosciences Of California's Raw Materials peaked at $46.0 million during Q2 2025, and registered a low of $4.5 million during Q1 2021.
  • Over the past 5 years, Pacific Biosciences Of California's median Raw Materials value was $24.6 million (recorded in 2024), while the average stood at $24.4 million.
  • As far as peak fluctuations go, Pacific Biosciences Of California's Raw Materials skyrocketed by 26242.06% in 2022, and later plummeted by 330.91% in 2024.
  • Over the past 5 years, Pacific Biosciences Of California's Raw Materials (Quarter) stood at $8.0 million in 2021, then skyrocketed by 202.0% to $24.1 million in 2022, then skyrocketed by 34.36% to $32.4 million in 2023, then soared by 39.58% to $45.3 million in 2024, then fell by 7.69% to $41.8 million in 2025.
  • Its Raw Materials was $41.8 million in Q3 2025, compared to $46.0 million in Q2 2025 and $44.5 million in Q1 2025.